Abstract

BioMimetic Therapeutics has reported encouraging findings from a pilot clinical study of Augment Injectable Bone Graft

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call